1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. Voiant Acquires Voxeleron

M&A Deal Summary

Voiant Acquires Voxeleron

On April 15, 2025, Voiant acquired software company Voxeleron

Acquisition Highlights
  • This is Voiant’s 1st transaction in the Software sector.
  • This is Voiant’s 3rd transaction in the United States.
  • This is Voiant’s 1st transaction in Texas.

M&A Deal Summary
Date 2025-04-15
Target Voxeleron
Sector Software
Buyer(s) Voiant
Deal Type Add-on Acquisition

Target

Voxeleron

Austin, Texas, United States
Voxeleron is an AI-driven ophthalmic image analysis, offering advanced solutions for applications in medicine, biology, and beyond. Voxeleron's platform provides image analysis software for all ophthalmic imagery, enabling researchers to accelerate clinical research, generate actionable results, and ultimately drive better patient outcomes. Voxeleron was formed in 2010 and is headquartered in Austin, Texas.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Voiant

Waltham, Massachusetts, United States
Category Company
Founded 1992
Sector Life Science
DESCRIPTION

Voiant is a provider of imaging core laboratory services and other blinded centralized review services for pharmaceutical and medical device clinical trials. Voiant was founded in 1992 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 3 of 3
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: Texas M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-13 MedQIA

Los Angeles, California, United States

MedQIA is a global, full service, contract research organization specializing in Quantitative Image Analysis for clinical trials. MedQIA provides a full range of CRO services and handles all aspects of your clinical trial from planning to completion. The company specializes in delivering cutting-edge quantitative imaging biomarkers in Phase I through IV studies for drugs and in medical devices. MedQIA is based in Los Angeles, California.

Buy -
Mergr

Solution for

Product

Company

Legal